88 related articles for article (PubMed ID: 22681384)
21. Maternal serum and amniotic fluid levels of macrophage inhibitory cytokine 1 in Down syndrome and chromosomally normal pregnancies.
Wallace EM; Marjono B; Brown DA; Crossley J; Tong S; Aitken D; Breit S
Prenat Diagn; 2004 Mar; 24(3):224-6. PubMed ID: 15057958
[TBL] [Abstract][Full Text] [Related]
22. [Study on key techniques and intervention in reducing birth defects].
Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
[TBL] [Abstract][Full Text] [Related]
23. Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid.
Perluigi M; di Domenico F; Fiorini A; Cocciolo A; Giorgi A; Foppoli C; Butterfield DA; Giorlandino M; Giorlandino C; Schininà ME; Coccia R
Proteomics Clin Appl; 2011 Apr; 5(3-4):167-78. PubMed ID: 21360684
[TBL] [Abstract][Full Text] [Related]
24. Are amniotic fluid C-reactive protein and glucose levels, and white blood cell counts at the time of genetic amniocentesis related with preterm delivery?
Tarim E; Bağiş T; Kiliçdağ EB; Sezgin N; Yanik F
J Perinat Med; 2005; 33(6):524-9. PubMed ID: 16318616
[TBL] [Abstract][Full Text] [Related]
25. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
[TBL] [Abstract][Full Text] [Related]
26. Urocortin in amniotic fluid and Down syndrome.
Torricelli M; Voltolini C; Biliotti G; Giorlandino C; De Pascalis F; De Bonis M; Mesuraca A; Giovannelli A; Pecciarini L; Petraglia F
Prenat Diagn; 2009 Aug; 29(8):806-7. PubMed ID: 19418477
[No Abstract] [Full Text] [Related]
27. Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome.
Charkiewicz K; Blachnio-Zabielska A; Zbucka-Kretowska M; Wolczynski S; Laudanski P
PLoS One; 2015; 10(5):e0127732. PubMed ID: 26000716
[TBL] [Abstract][Full Text] [Related]
28. Organic acid concentrations in amniotic fluid found in normal and Down syndrome pregnancies.
Baggot PJ; Eliseo AJ; DeNicola NG; Kalamarides JA; Shoemaker JD
Fetal Diagn Ther; 2008; 23(3):245-8. PubMed ID: 18417986
[TBL] [Abstract][Full Text] [Related]
29. The frequency and clinical significance of intra-amniotic inflammation in patients with a positive cervical fetal fibronectin.
Yoon BH; Romero R; Moon JB; Oh SY; Han SY; Kim JC; Shim SS
Am J Obstet Gynecol; 2001 Nov; 185(5):1137-42. PubMed ID: 11717647
[TBL] [Abstract][Full Text] [Related]
30. Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum.
Lopez MF; Kuppusamy R; Sarracino DA; Prakash A; Athanas M; Krastins B; Rezai T; Sutton JN; Peterman S; Nicolaides K
J Proteome Res; 2011 Jan; 10(1):133-42. PubMed ID: 20499897
[TBL] [Abstract][Full Text] [Related]
31. S100B content and SOD activity in amniotic fluid of pregnancies with Down syndrome.
Netto CB; Siqueira IR; Fochesatto C; Portela LV; da Purificação Tavares M; Souza DO; Giugliani R; Gonçalves CA
Clin Biochem; 2004 Feb; 37(2):134-7. PubMed ID: 14725944
[TBL] [Abstract][Full Text] [Related]
32. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
Kolialexi A; Tsangaris GT; Papantoniou N; Anagnostopoulos AK; Vougas K; Bagiokos V; Antsaklis A; Mavrou A
Prenat Diagn; 2008 Aug; 28(8):691-8. PubMed ID: 18551720
[TBL] [Abstract][Full Text] [Related]
33. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis.
Kang Y; Dong X; Zhou Q; Zhang Y; Cheng Y; Hu R; Su C; Jin H; Liu X; Ma D; Tian W; Li X
Prenat Diagn; 2012 Mar; 32(3):284-92. PubMed ID: 22430729
[TBL] [Abstract][Full Text] [Related]
35. Predictive power of maternal serum and amniotic fluid CRP and PAPP-A concentrations at the time of genetic amniocentesis for the preterm delivery.
Ozer KT; Kavak ZN; Gökaslan H; Elter K; Pekin T
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):187-90. PubMed ID: 16219520
[TBL] [Abstract][Full Text] [Related]
36. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection.
Chow SS; Craig ME; Jones CA; Hall B; Catteau J; Lloyd AR; Rawlinson WD
Cytokine; 2008 Oct; 44(1):78-84. PubMed ID: 18703348
[TBL] [Abstract][Full Text] [Related]
37. Molecular weight forms of inhibin A, inhibin B and pro-alphaC in maternal serum, amniotic fluid and placental extracts of normal and Down syndrome pregnancies.
Thirunavukarasu PP; Lambert-Messerlian G; Robertson DM; Dawson G; Canick J; Wallace EM
Prenat Diagn; 2002 Dec; 22(12):1086-92. PubMed ID: 12454963
[TBL] [Abstract][Full Text] [Related]
38. Increased levels of human placental growth hormone in the amniotic fluid of pregnancies affected by Down syndrome.
Sifakis S; Papadopoulou E; Konstantinidou A; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2009 Apr; 19(2):121-5. PubMed ID: 18793862
[TBL] [Abstract][Full Text] [Related]
39. Amniotic fluid S100B protein and erythropoietin in pregnancies at risk for fetal hypoxia.
Loukovaara M; Teramo K; Alfthan H; Hämäläinen E; Stefanovic V; Andersson S
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):115-8. PubMed ID: 19042077
[TBL] [Abstract][Full Text] [Related]
40. Amniotic fluid angiogenin levels are decreased in pregnancies with fetal trisomy 21.
Demir A; Guclu S; Bige O; Solak A; Demir N
Prenat Diagn; 2011 Nov; 31(11):1101-3. PubMed ID: 21800332
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
